Statistics for QIAGEN NV (id:8873 QGEN)
Valuation metrics
Market cap
9.97B
Enterprise value
10.38B
Trailing P/E (ttm)
99.64
Forward P/E
19.58
PEG ratio
19.58
Price/Sales (ttm)
5.07
Price/Book (mrq)
2.82
Enterprise Value/Revenue
5.28
Enterprise Value/EBITDA
15.51
Overview
Shares outstanding
222.26M
Float
220.33M
Shares short
3.71M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
889.30K
Average volume (90 days)
Price summary
52-Week low
39.03
52-Week high
47.44
52-Week change
2.71%
Beta
3.00
50-Day moving average
43.29
200-Day moving average
43.49
Dividends and splits
Forward annual dividend rate
5.28
Forward annual dividend yield
3.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
January 30, 2024
Ex-dividend date
January 30, 2024
Last split factor
2:1
Last split date
January 25, 2017
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
4.73%
Operating margin
25.79%
Operational effectiveness
Return on assets
4.84%
Return on equity
2.57%
Income statement
Revenue (ttm)
8.84
Revenue per share (ttm)
8.84
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
1.23B
EBITDA
723.86M
Net income to common (ttm)
92.93M
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
26.00%
Balance sheet
Total cash (mrq)
1.48B
Total cash per share (mrq)
6.66
Total debt (mrq)
2.01B
Total Debt/Equity (mrq)
57.02
Current ratio (mrq)
217.50%
Book value per share (mrq)
15.88
Cash flow
Cash flow statement
633.41M
Levered free cash flow (LFCF)
396.84M